| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2ada0c84b58f625ac567278db73cccf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate |
2001-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c63e441ea0181a9d7a325d468a4c257 |
| publicationDate |
2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003039615-A1 |
| titleOfInvention |
Method for treating bronchial constriction and bronchospasm |
| abstract |
The present invention is directed to a method for treating bronchial constriction in mammals. The method comprises contacting mammalian lung with a compound selected from the group consisting of pyruvate and pyruvate precursors. The compound is present in a therapeutically effective amount to produce bronchial dilation. The present invention is also directed to a method for treating airway disease in mammals. The method comprises contacting mammalian lung with a compound selected from the group consisting of pyruvate and pyruvate precursors. The compound is present in an amount from about 0.0001 millimoles to about 0.005 millimoles. The present invention is further directed to a method for treating airway disease in mammals. The method comprises contacting the mammalian lung with a compound selected from the group consisting of pyruvate and pyruvate precursors. The compound is present in a therapeutically effective amount to prevent bronchial spasm. The present invention is still further directed to a method for treating airway disease in mammals. The method comprises contacting the mammalian lung with a compound selected from the group consisting of pyruvate and pyruvate precursors. The compound is present in a therapeutically effective amount to prevent bronchial constriction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10124066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015328244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328071-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1490328-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11395830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2470582-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1490328-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10251900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828314-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011112535-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446318-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10064882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571386-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10588918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895385-B2 |
| priorityDate |
2001-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |